ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Leveraging efferocytosis blockade for improved cancer chemo-immunotherapy through synchronized release of doxorubicin and BMS777607 confined within tailored mesoporous silica nanoparticles

Zhang, Jing-Yang; Chen, Fang-Man; Li, Yu-Xuan; Duan, Qi-Jia; Wu, Chong; Zheng, Sui-Juan; Leong, Kam W.; Shao, Dan*; Du, Jin-Zhi*中山大学; 1
Nano Today2023-12DOI: 10.1016/j.nantod.2023.102039
5阅读
引用收藏
分享

摘要

Effective antitumor activity of chemotherapy can be counterbalanced by efferocytosis by generating immunosuppressive tumor microenvironment. Targeted blocking efferocytosis at an early stage of cell apoptosis exerts promising benefits on achieving improved chemotherapy, but it appears to have considerably limited outcome due to the uncontrolled release of chemotherapeutic and efferocytosis inhibitors. Herein, a mesoporous silica nanoparticle (MSN)-based nanoconfined assembly strategy is created to co-deliver chemotherapeutic drug doxorubicin (DOX) and efferocytosis inhibitor BMS777607 (BMS) for efficient cancer chemo-immunotherapy. DOX and BMS self-assembly forms nanoparticulate crystal confined within the mesopore of tailor-made MSN, and nanocrystal-encapsulated MSN (denoted as SC-MSN@D/B) enables synchronized drug release behaviors, which is beneficial for efferocytosis blockade at the early stage of apoptosis. Consequently, intravenous injection of SC-MSN@D/B leads to a synergistic inhibition of tumor growth in colon and breast cancer models through inducing a stimulatory immune response, from the secretion of pro-inflammatory cytokines to the inhibition of tumor associated macrophages and regulatory T cells infiltration. The combination of SC-MSN@D/B with checkpoint blockade inhibitors further amplifies the therapeutic effect of on tumor growth and pulmonary metastasis of orthotopic 4T1 breast tumors, and establishes long-term immune memory, offering tremendous potential for a combined efferocytosis-blocking strategy in cancer chemo-immunotherapy.

学科与关键词

关键词
ChemotherapeuticsEfferocytosisNanoconfinement effectCancer chemo-immunotherapyMesoporous silica nanoparticles
相关
加载中…
  • Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy
    Luo, Jia-Qi; Liu, Rong; Chen, Fang-Man; Zhang, Jing-Yang; Zheng, Sui-Juan; Shao, Dan; Du, Jin-Zhi*ACS Nano, 2023, 17(10): 8966-8979.被引 14
  • Novel biomimetic mesoporous silica nanoparticle system possessing targetability and immune synergy facilitates effective solid tumor immuno-chemotherapy
    Zhu, Haoran; Liu, Yang; Yi, Xinfeng; Zhu, Chuyun; Fu, Yuanyue; Huang, Zerong; Zhu, Kairui; Zhang, Wencai; Hou, Huige; Sun, Chenghong; Zhong, Cheng; Liu, Wei*; Li, Zhizhong*; Wang, Baocheng*; Wo, Jin*BIOMATERIALS ADVANCES, 2023, 144: 213229.被引 5
  • An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
    Yuan, Xinyuan; Wang, Xiupeng*Nanomaterials, 2023, 13(24): 3144.
查看全部 →

发表信息

论文状态
公开发表
期刊
Nano Today
发表日期
2023-12
卷期
第 53 卷
页码
102039
DOI
10.1016/j.nantod.2023.102039
语言
ENGLISH
成果收录
SCIE
资助标注
National Key R & D Program of China [2022YFC3401400]; National Natural Science Foundation of China [52173122, 51922043]; Guangdong Basic and Applied Basic Research Foundation [2022B1515120028]; Fundamental Research Funds for Central Universities

作者

  • Z

    Zhang, Jing-Yang (第一作者)

  • C

    Chen, Fang-Man

查看全部 9 位作者收起作者
  • L

    Li, Yu-Xuan

  • D

    Duan, Qi-Jia

  • W

    Wu, Chong

    1 · sun yat sen univ

  • Z

    Zheng, Sui-Juan

  • L

    Leong, Kam W.

    new

  • S

    Shao, Dan (通讯)

  • D

    Du, Jin-Zhi (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417